切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2019, Vol. 05 ›› Issue (06) : 345 -348. doi: 10.3877/cma.j.issn.2095-9141.2019.06.006

所属专题: 文献

临床研究

慢性硬膜下血肿复发的影像学因素分析
张毅1, 严红燕1, 彭强2, 戴勇1, 王蕾2,()   
  1. 1. 226001 南通,南通大学第二附属医院神经外科
    2. 226001 南通,南通大学第二附属医院急诊中心
  • 收稿日期:2019-06-10 出版日期:2019-12-15
  • 通信作者: 王蕾
  • 基金资助:
    江苏省科技厅自然科学基金(BK20161290); 南通市科技计划项目(MS12015109); 南通市卫计委科研项目(WKZL2018024)

Analysis on imaging related factors of recurrence of chronic subdural hematoma

Yi Zhang1, Hongyan Yan1, Qiang Peng2, Yong Dai1, Lei Wang2,()   

  1. 1. Department of Neurosurgery, the Second Hospital Affiliated to Nantong University, Nantong 226001, China
    2. Department of Emergency Center, the Second Hospital Affiliated to Nantong University, Nantong 226001, China
  • Received:2019-06-10 Published:2019-12-15
  • Corresponding author: Lei Wang
  • About author:
    Corresponding author: Wang Lei, Email:
引用本文:

张毅, 严红燕, 彭强, 戴勇, 王蕾. 慢性硬膜下血肿复发的影像学因素分析[J]. 中华神经创伤外科电子杂志, 2019, 05(06): 345-348.

Yi Zhang, Hongyan Yan, Qiang Peng, Yong Dai, Lei Wang. Analysis on imaging related factors of recurrence of chronic subdural hematoma[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2019, 05(06): 345-348.

目的

通过影像学检查评估慢性硬膜下血肿(CSDH)复发的危险因素。

方法

收集2014年1月至2018年12月在南通大学第二附属医院神经外科接受CSDH手术治疗的113例患者的临床资料。所有患者均接受钻孔外引流手术治疗,术后随访时间超过3个月,比较复发组与未复发组患者的临床资料,采用多因素Logistic回归分析CSDH患者复发的危险因素。

结果

113例患者中,术后复发患者10例,未复发患者103例,术后复发率8.8%。复发组患者与非复发组患者在性别、年龄、术前血肿厚度、中线偏移比较差异均无统计学意义(P>0.05),复发组与未复发组患者的血肿类型、血肿侧别比较,差异均具有统计学意义(P<0.05)。将单因素分析中有统计学意义的变量纳入Logistic回归分析,结果显示术前分隔分层和双侧血肿是CSDH复发的独立危险因素。

结论

影像学术前血肿分隔分层型和双侧血肿是CSDH复发的危险因素。

Objective

To evaluate and predict the related factors of chronic subdural hematoma (CSDH) recurrence by imaging examination.

Methods

Clinical data of 113 patients who underwent surgical treatment of CSDH in neurosurgery at the Second Hospital Affiliated to Nantong University from January 2014 to December 2018 were collected. All patients underwent external drainage surgery. The follow-up time was more than 3 months. The clinical data of patients with relapse and non-recurrence were compared. Multivariate logistic regression was used to analyze the risk factors of recurrence in CSDH patients.

Results

Of the 113 patients, 10 had recurrence and 103 had no recurrence, and the recurrence rate was 8.8%. There were no significant differences in gender, age, preoperative hematoma thickness and midline deviation between the relapsed group and the non-recurrent group (P>0.05). The hematoma type and hematoma side of the relapsed group and the non-recurrent group were compared. The differences were statistically significant (P<0.05). Statistically significant variables in the univariate analysis were included in the logistic regression analysis. The results showed that preoperative stratification and bilateral hematoma were independent risk factors for CSDH recurrence.

Conclusion

The risk factors for the recurrence of CSDH are the types of hematoma separation and stratification and bilateral hematoma before imaging.

表1 复发组和非复发组的相关因素比较
表2 血肿术后复发因素Logistic回归分析
[1]
白金鑫,王跃彬,陈宁,等.慢性硬膜下血肿的治疗研究进展[J].临床医药实践, 2018, 27(3): 210-213.
[2]
胡杨杨,戴易.慢性硬膜下血肿治疗新策略[J].沈阳医学院学报, 2018, 20(2): 174-177.
[3]
Lee JM, Park JC, Kim JH. Retrospective analysis of risk factors for recurrent chronic subdural hematoma[J]. Nerve, 2016, 2(2): 54-58.
[4]
Jeong SI, Kim SO, Won YS, et al. Clinical analysis of risk factors for recurrence in patients with chronic subdural hematoma undergoing burr hole trephination[J]. Korean J Neurotrauma, 2014, 10(1): 15-21.
[5]
文传志.慢性硬膜下血肿术后复发因素分析[J].中国社区医师, 2019, 35(1): 73-74.
[6]
胡杨杨,狄广福,徐宗华,等.慢性硬膜下血肿术后复发危险因素分析及防治策略[J].皖南医学院学报, 2018, 37(2): 170-172.
[7]
Delgado Almandoz JE, Yoo AJ, Stone MJ, et al. The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors[J]. Stroke, 2010, 41(1): 54-60.
[8]
Li Q, Liu QJ, Yang WS, et al. Island sign: an imaging predictor for early hematoma expansion and poor outcome in patients with intracerebral hemorrhage[J]. Stroke, 2017, 48(11): 3019-3025.
[9]
Kuwabara M, Sadatomo T, Yuki K, et al. The effect of irrigation solutions on recurrence of chronic subdural hematoma: a consecutive cohort study of 234 patients[J]. Neurol Med Chir (Tokyo), 2017, 57(5): 210-216.
[10]
Kim J, Moon J, Kim T, et al. Risk factor analysis for the recurrence of chronic subdural hematoma: a review of 368 consecutive surgical cases[J]. Korean J Neurotrauma, 2015, 11(2): 63-69.
[11]
Hammer A, Tregubow A, Kerry G, et al. Predictors for recurrence of chronic subdural hematoma[J]. Turk Neurosurg, 2016, 27(5): 756-762.
[12]
Yan C, Yang MF, Huang YW. A reliable nomogram model to predict the recurrence of chronic subdural hematoma after burr hole surgery[J]. World Neurosurg, 2018, 118: e356-e366.
[13]
Yamamoto H, Hirashima Y, Hamada H, et al. Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model[J]. J Neurosurg, 2003, 98(6): 1217-1221.
[14]
Lee JM, Park JC, Kim JH. Retrospective analysis of risk factors for recurrent chronic subdural hematoma[J]. Nerve, 2016, 2(2): 54-58.
[15]
Jung YG, Jung NY, Kim E. Independent predictors for recurrence of chronic subdural hematoma[J]. J Korean Neurosurg Soc, 2015, 57(4): 266-270.
[16]
Hammer A, Tregubow A, Kerry G, et al. Predictors for recurrence of chronic subdural hematoma[J]. Turk Neurosurg, 2017, 27(5): 756-762.
[17]
Tokmak M, Iplikcioglu AC, Bek S, et al. The role of exudation in chronic subdural hematomas[J]. J Neurosurg, 2007, 107(2): 290-295.
[18]
Song DH, Kim YS, Chun HJ, et al. The predicting factors for recurrence of chronic subdural hematoma treated with burr hole and drainage[J]. Korean J Neurotrauma, 2014, 10(2): 41-48.
[1] 叶艳娜, 叶瑞婷, 陈艳玲, 彭雯, 刘乐, 肖文秋, 黄辉, 李明深, 钟慕仪, 叶娴. 基于影像学表现和临床病理特征预测良性与交界性乳腺叶状肿瘤复发的列线图模型[J]. 中华乳腺病杂志(电子版), 2023, 17(04): 229-237.
[2] 崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.
[3] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[4] 阿冲罗布, 陈颖, 谢德坤. 腹腔镜外囊完整剥离术治疗肝包虫病效果及对患者肝功能、预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 666-669.
[5] 郑泽坤, 刘卓恒, 邹浩, 胡会元, 李妲, 吴巍. 扩大根治性手术切除复发性巨大腹膜后去分化脂肪肉瘤1例[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 588-590.
[6] 罗辉, 熊珍珍, 黄令杰, 林山, 李金雨. 盆腔淋巴结大小对膀胱癌复发的影响[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 495-499.
[7] 邢晓伟, 刘雨辰, 赵冰, 王明刚. 基于术前腹部CT的卷积神经网络对腹壁切口疝术后复发预测价值[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 677-681.
[8] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[9] 蒋正东, 李徐奇, 王曙逢, 魏光兵. 复发性腹股沟疝的腹腔镜手术策略及疗效观察[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 539-543.
[10] 韦笑韩, 任振, 潘晨, 吴立胜. 再次经腹腹膜前腹腔镜修补术治疗复发性腹股沟疝的专科单中心疗效分析[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 385-389.
[11] 孙中伟, 郭宏坤, 薛意恒, 孟岩. 脱细胞基质补片和聚丙烯补片在腹腔镜腹股沟疝修补术后复发的对比研究[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 419-422.
[12] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[13] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[14] 张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要